Reports the stem cell technology market could exceed $1 billion in 2012

cord blood banking, stem cells, regenerative medicineIn a new report titled, "Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development" published by Kalorama Information it is predicted the stem cell technology market will hit $700 million in 2012 and a possibility to exceed $1 billion.

Among numerous factors that will contribute to the growing success of the stem cell technology market, principally it is the selection of current technologies under development that should prove safe, clear regulations and show substantial benefits over current therapies.

Cord blood banking is also stated to be an excellent source of revenue growth as it continues to increase in popularity as the least controversial supply of stem cells acquired by the industry.

At the World Stem Cells & Regenerative Medicine Congress in London, Greg Bonfiglio, Managing Partner of Proteus Venture Capital will present on the benefits of private cord blood banking and how it can be incorporated into your existing business model.

Early bird registration is now open so check out to full agenda here and register early for the most economical delegate rate.

Read original article here